Nicholas A Saccomano Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity
Nicholas A Saccomano is President and CEO of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 4,556 shares of RPHM, which is worth approximately $7,654. The most recent transaction as insider was on Oct 04, 2024, when has been sold 4,556 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
4.56K
n/a
3M change
n/a
12M change
Total Value Held
$7,654
NAS
Nicholas A Saccomano
President and CEO
Boulder, CO